Pilot study for the consumption of food product made from KluayNamwa(Musa sapientum L. ABB cv.) on safety and effect to control glycemic index and lipid profile in healthy volunteer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200128002

Enrollment

Unknown

Registered

2020-01-28

Start date

2020-02-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy conditions KluayNamwa glycemic index lipid profile fasting blood glucose

Interventions

Subjects are received food product made from Kluay Namwa fiber 1 g per day,Subjects are received food product made from Kluay Namwa fiber 3 g per day

Experimental Dietary Supplement,Experimental Dietary Supplement

Food product plus Kluay Namwa fiber 5 percent,Food product plus Kluay Namwa fiber 10 percent

Eligibility

Sex/Gender

Female

Age

35 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Healthy women aged between 35-60 years old 2. Body mass index (BMI) > 23 kg/m2 3. Without being pregnant or breastfeeding

Exclusion criteria

Exclusion criteria: 1. Diagnosed with cardiovascular diseases, respiratory diseases, neuropsychological diseases, head injury, diabetes mellitus, liver disease, cancer, autoimmune diseases and hematological disorder 2. Chronic diseases include: liver, kidney, heart and hematological disorder 3. Using supplements or herbs or drugs at least 1 months before participating in this study 4. Volunteers who require supplements or drugs that effect on body weight, blood sugar and lipid control 5. Smoking more than 10 pieces/day 6. Alcohol addiction or using addictive substances 7. Regular excercise more than 3 times/week 8. Blood pressure > 140/90 mmHg

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose and lipid profiles 2 hours for single dose effect laboratory,Fasting blood glucose 3 months glucometer, photometric method,Plasma lipid profiles 3 months laboratory	—

Secondary

Measure	Time frame
HbA1c 3 months laboratory,The changes of hematological and clinical chemistry parameters 3 months laboratory,Body Mass Index 3 months equipment ,Electrocardiogram 3 months electrocardiograph,Safety evaluation and side effect 3 months Questionaires,Homeostasis Model Assessment Insulin Resistance (HOMA-IR) 3 months laboratory,Stool examination(total Lactic acid bacteria, lactobacillus spp., bifidobacterium spp., short chain) 3 months laboratory,Body Composition 3 months equipment	—

Measure

Time frame

HbA1c 3 months laboratory,The changes of hematological and clinical chemistry parameters 3 months laboratory,Body Mass Index 3 months equipment ,Electrocardiogram 3 months electrocardiograph,Safety evaluation and side effect 3 months Questionaires,Homeostasis Model Assessment Insulin Resistance (HOMA-IR) 3 months laboratory,Stool examination(total Lactic acid bacteria, lactobacillus spp., bifidobacterium spp., short chain) 3 months laboratory,Body Composition 3 months equipment

—

Countries

Thailand

Contacts

Public ContactSupaporn Muchimapura

Khon Kaen University

supmuc@kku.ac.th+6681-2607998

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026